Cargando…
Cardiac Rehab in the COVID Era and Beyond: mHealth and Other Novel Opportunities
PURPOSE OF REVIEW: The COVID-19 pandemic has forced many center-based cardiac rehabilitation (CBCR) programs to close or limit their usual offerings. In order for patients to continue to benefit from CR, programs need to rapidly adapt to the current environment. This review highlights ways CR has ev...
Autores principales: | Epstein, Elizabeth, Patel, Neeja, Maysent, Kathryn, Taub, Pam R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7947942/ https://www.ncbi.nlm.nih.gov/pubmed/33704611 http://dx.doi.org/10.1007/s11886-021-01482-7 |
Ejemplares similares
-
PCSK9 Inhibitor Wars: How Does Inclisiran Fit in with Current Monoclonal Antibody Inhibitor Therapy? Considerations for Patient Selection
por: Arnold, Natalie, et al.
Publicado: (2022) -
The Clinical Importance of Differentiating Monogenic Familial Hypercholesterolemia from Polygenic Hypercholesterolemia
por: Tandirerung, Fistra Janrio
Publicado: (2022) -
Is Lipoprotein(a) Clinically Actionable with Today’s Evidence? The Answer is Yes
por: Ma, Gary S., et al.
Publicado: (2023) -
Reasons Why Combination Therapy Should Be the New Standard of Care to Achieve the LDL-Cholesterol Targets: Lipid-lowering combination therapy
por: Masana, Lluís, et al.
Publicado: (2020) -
Familial Hypercholesterolemia: Present and Future Management
por: Sjouke, B., et al.
Publicado: (2011)